GENMAB A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,562.00 DKK | -0.83% |
|
-1.10% | +5.53% |
| 12:00am | Genmab A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 03:00 PM | |
| 01-02 | A poor 2024 increases the odds of a brighter 2025 |  |
Main competitors
| Net sales (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 2,271,038,537.62 | +26.42% | +32.30% | 14.78x | 13.31x | -5.01x | ||
| 9,869,200,000.00 | +36.68% | +44.33% | 22.99x | 17.71x | -2.46x | ||
| 13,117,200,000.00 | +30.14% | +39.08% | 20.74x | 16.2x | -1.6x | ||
| 1,205,386,308.42 | -23.26% | -33.51% | -8.54x | -7.69x | 10.14x | ||
| 3,931,439,159.98 | +24.36% | +18.08% | 4.62x | 4.02x | -13.1x | ||
| 5,502,694,940.73 | +26.50% | +29.43% | 18.99x | 15.45x | -0.64x | ||
| 2,458,779,000.00 | -35.86% | -49.12% | -22.26x | -14.47x | 2.05x | ||
| 1,887,100,000.00 | +13.23% | +13.30% | 12.68x | 8.89x | -5.76x | ||
| 305,208,000.00 | -245.59% | -232.51% | - | -50.2x | -0.8x | ||
| 1,243,336,000.00 | -43.11% | -21.54% | -86.15x | -1.86x | 1.96x | ||
| 1,830,208,000.00 | +11.35% | +9.34% | 8.74x | 6.91x | -5.06x | ||
| 2,323,560,584.36 | +19.96% | +24.97% | 9.02x | 6.41x | -0.78x | ||
| 274,570,722.67 | -180.51% | -170.79% | -818.43x | -50.27x | -0.33x | ||
| 154,753,121.97 | -12.22% | -37.48% | -3.46x | -2.93x | 11.91x | ||
| 47,255,357.43 | -205.30% | -166.94% | -58.43x | - | 2.98x | ||
| 617,404,345.87 | +44.81% | +45.26% | 55.36x | 27.64x | 0.65x | ||
| Average | 2,939,945,879.94 | -32.02% | -28.49% | -55.29x | -0.73x | -0.37x | |
| Weighted average by Cap. | 6,331,935,245.23 | +1.02% | +4.44% | -8.54x | 6.44x | -0.97x |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition